Oxford Immunotec debuted its IPO on Friday after having priced 5,360,000 shares at $12 per share. The stock is trading on the NASDAQ under the ticker symbol "OXFD." J.P. Morgan and Piper Jaffray & Co. are serving as lead underwriters. Headquartered near Oxford, UK and in Marlborough, Mass., Oxford Immunotec is a diagnostics company that focuses on immunological diseases. Its backers include Clarus Ventures, New Leaf Venture Partners, DFJ Esprit, Imperial Innovations, Wellington, Invesco, SPARK Ventures and Kaiser Permanente Ventures.
2 min read · 25 November 2013
TapCommerce said Friday that it has closed $10.5 million in Series A funding. Bain Capital Ventures and RRE Ventures led the round with participation from Nielsen Ventures and return backers Metamorphic Ventures, Eniac Ventures and Nextview Ventures. Also, Bain Capital's Scott Friend of Bain Capital and RRE Ventures' Eric Wiesen have joined TapCommerce's board of directors. Based in New York City, TapCommerce is a provider of mobile retargeting solutions.
2 min read · 25 November 2013
Flagship VentureLabs, a unit of Flagship Ventures, has launched Seres Health after two years in stealth mode. During that period, Seres Health received $10.5 million in Series A financing from Flagship Ventures and various unnamed investors. Also, Seres Health has named Dr. Roger J. Pomerantz as chairman of its board of directors. Based in Cambridge, Mass., Seres Health is a clinical stage biotherapeutic company focused on developing drugs that target the human microbiome.
5 min read · 25 November 2013
According to AllThingsD, online shopping website Gilt Groupe may be launching an IPO in the fourth quarter of 2014. The site also reported that unlike the previous times in which the company flirted with the idea, this time it may be true. Gilt Groupe has not hired any banks for the IPO so it's possible the launch could be pushed into early 2015. Gilt Groupe is backed by Matrix Partners, General Atlantic, Goldman Sachs, NEA, Draper Fisher Jurvetson, Pinnacle Ventures, TriplePoint Capital, Eastward Capital Partners, GSV Capital and SoftBank Capital.
1 min read · 22 November 2013
Livefyre has acquired Realtidbits. No financial terms were disclosed. Based in San Diego, Realtidbits is a provider of engagement solutions for publishers and media companies. Livefyre is a real-time conversation and social curation platform. It is backed by Greycroft Partners, Hillsven Capital, Zelkova Ventures, ff Venture Capital, Cue Ball and U.S. Venture Partners.
3 min read · 22 November 2013
Oxford Immunotec debuted its IPO on Friday after having priced 5,360,000 shares at $12 per share. The stock is trading on the NASDAQ under the ticker symbol "OXFD." J.P. Morgan and Piper Jaffray & Co. are serving as lead underwriters. Headquartered near Oxford, UK and in Marlborough, Mass., Oxford Immunotec is a diagnostics company that focuses on immunological diseases. Its backers include Clarus Ventures, New Leaf Venture Partners, DFJ Esprit, Imperial Innovations, Wellington, Invesco, SPARK Ventures and Kaiser Permanente Ventures.
2 min read · 22 November 2013
TapCommerce said Friday that it has closed $10.5 million in Series A funding. Bain Capital Ventures and RRE Ventures led the round with participation from Nielsen Ventures and return backers Metamorphic Ventures, Eniac Ventures and Nextview Ventures. Also, Bain Capital's Scott Friend of Bain Capital and RRE Ventures' Eric Wiesen have joined TapCommerce's board of directors. Based in New York City, TapCommerce is a provider of mobile retargeting solutions.
2 min read · 22 November 2013
Flagship VentureLabs, a unit of Flagship Ventures, has launched Seres Health after two years in stealth mode. During that period, Seres Health received $10.5 million in Series A financing from Flagship Ventures and various unnamed investors. Also, Seres Health has named Dr. Roger J. Pomerantz as chairman of its board of directors. Based in Cambridge, Mass., Seres Health is a clinical stage biotherapeutic company focused on developing drugs that target the human microbiome.
5 min read · 22 November 2013
Alpine Data Labs said Friday that it has raised $16 million in Series B funding. The investors were Sierra Ventures, Mission Ventures, UMC Capital and Robert Bosch Venture Capital GmbH. Based in San Francisco, Alpine Data Labs is a provider of big data analytics solutions.
3 min read · 22 November 2013
Finjan Holdings has made an undisclosed investment in an unidentified Israel-based venture capital fund. The pool will focus on early-stage tech companies "on the leading edge of cybersecurity innovation."
3 min read · 22 November 2013
